Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06457425
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-06-07
Brief Title:
Flunotinib Maleate Phase II Intermediate-High Risk Bone Fiber Clinical Trial
Sponsor:
Chengdu Zenitar Biomedical Technology Co Ltd
Organization:
Chengdu Zenitar Biomedical Technology Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-07
First Submit QC Date:
June 7 2024
Study First Post Date:
2024-06-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-07
Last Update Post Date:
2024-06-13
Last Update Post Date Type:
ACTUAL